Amedrix Exit

Amedrix develops & produces three dimensional implants (gel and liquid) based on collagen. Focus: treatment of articular cartilage damage in human an horse and other promising application areas. CE-mark for the cartilage repair product is granted & successfully used in patients.

Info & Contact

Dr. Thomas Graeve
Phone:
+49 711 93341450
Web:
www.amedrix.de

Address

Schelztorstraße 54-56
73728 Esslingen

In portfolio

01. Dec 2009 – 15. Jul 2013

HTGF Manager

 
Dr. Martin Pfister, Principal / Authorized Signatory
Exit